Armata Pharmaceuticals Inc (ARMP)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4503 GLENCOE AVENUE MARINA DEL REY, CA 90292

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of the United Statesand Canada, Armata is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.

Data as of 2021-07-19 08:57:25 -0400
Market Cap93.527 Million Shares Outstanding24.94 Million Avg 30-day Volume10.631 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.22509 52-week High/Low10.48 / 2.56 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from ARMP instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARMP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARMP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PATTI JOSEPH M

  • Director
28,000 2021-06-07 2

PETERSON TODD C.

  • Director
28,000 2021-06-07 2

SCHLESINGER SARAH J.

  • Director
28,000 2021-06-07 2

ODYSSEAS KOSTAS D

  • Director
28,000 2021-06-07 2

KRAMER ROBIN

  • Director
28,000 2021-06-07 3

HAIMOVITZ JULES

  • Director
30,000 2021-04-01 2

MARTIN STEVEN ROBERT CHIEF FINANCIAL OFFICER

  • Officer
56,000 2021-03-25 2

PATRICK TODD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
112,000 2021-03-25 2

MORRIS DUANE ALFRED VP OF OPERATIONS

  • Officer
28,000 2021-03-25 2

VARNUM BRIAN PRESIDENT AND CDO

  • Officer
112,000 2021-03-25 2

INNOVIVA, INC.

INNOVIVA STRATEGIC OPPORTUNITIES LLC

  • Director
  • 10% Owner
29,729,294 2021-03-17 2

BASTIANI RICHARD

  • Director
0 2020-12-08 1

INNOVIVA, INC.

  • 10% Owner
8,710,800 2020-03-27 2

COOK JEREMY CURNOCK

  • Director
0 2019-12-31 0

PERRY MICHAEL S

  • Director
No longer subject to file 2019-12-31 0

PARKER H STEWART

  • Director
0 2019-05-22 0

BEAR RICHARD

  • Director
0 2019-05-22 0

DELTA DENTAL PLAN OF MICHIGAN, INC.

RENAISSANCE HOLDING CO

  • 10% Owner
1,265,802 2019-05-09 0

DELTA DENTAL OF WISCONSIN, INC.

  • 10% Owner
2,107,675 2019-05-09 0

GRINT PAUL C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
599 2017-12-08 0

DRAPEAU LOUIS

  • Director
0 2017-09-07 0

JOHNSON WENDY S.

  • Director
0 2017-09-07 0

SAMANT VIJAY B

  • Director
0 2017-09-07 0

BILINSKY IGOR CHIEF OPERATING OFFICER

  • Officer
0 2017-05-30 0

SALKA MICHAEL SCOTT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2017-04-01 0

KIRK RANDAL J

INTREXON CORP

  • 10% Owner
No longer subject to file 2016-12-27 0

KIRK JULIAN P.

  • Director
0 2015-09-21 0

WILLIAMS GWYNN

  • 10% Owner
0 2014-02-18 0

YOUNG PHILIP J PRESIDENT AND CEO

  • Officer
  • Director
0 2014-02-18 0

WENDT KELLEY A CHIEF FINANCIAL OFFICER

  • Officer
0 2014-02-18 0

POSTON DAVID J VICE PRESIDENT AND CFO

  • Officer
220,576 2010-04-16 0

ROBINSON BG SUSAN PRESIDENT AND CEO

  • Officer
  • Director
310,814 2010-04-16 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
0 2009-10-09 0

DAVIE JOSEPH MD PHD

  • Director
0 2009-05-29 0

LEVY NELSON L

  • Director
0 2009-05-29 0

HAWLEY ROGER

  • Director
0 2009-05-29 0

CARTER BARRIE J PHD EXECUTIVE VICE PRESIDENT

  • Officer
83,766 2008-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SCHLESINGER SARAH J. - Director

2021-06-09 16:26:39 -0400 2021-06-07 A 28,000 a 28,000 direct

PATTI JOSEPH M - Director

2021-06-09 16:26:17 -0400 2021-06-07 A 28,000 a 28,000 direct

ODYSSEAS KOSTAS D - Director

2021-06-09 16:25:16 -0400 2021-06-07 A 28,000 a 28,000 direct

PETERSON TODD C. - Director

2021-06-09 16:26:19 -0400 2021-06-07 A 28,000 a 28,000 direct

KRAMER ROBIN - Director

2021-06-09 16:25:47 -0400 2021-06-07 A 28,000 a 28,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 22:15:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 21:45:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 21:15:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 20:45:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 20:15:05 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 19:45:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 19:15:03 UTC -55.0065 55.0865 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 18:45:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 18:15:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 17:45:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 17:15:02 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 16:45:02 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 16:15:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 15:45:02 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 15:15:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 14:45:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 14:15:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 13:45:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 13:15:03 UTC -55.2125 55.2925 20000
ARMATA PHARMACEUTICALS INC ARMP 2021-07-23 12:45:03 UTC -55.2125 55.2925 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments